Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from McKesson

Red-Hot Medical Stock McKesson Tacks Onto Its 35% Gain With A Brief Breakout

McKesson stock briefly broke out Monday after the drug distributor raised its dividend and announced a new deal for a cancer-related drug.

Investors Business Daily

Dow Jones Futures: Market Rallies Back As Fed Hawks Say This; Tesla Rival Soars

Once again, stocks rallied off lows, as hawkish Fed members took a dovish tone. But it's a tough market. Tesla rival BYD jumped on guidance.

Investors Business Daily

Dow Jones Futures Fall Sharply As Fed Ready For 'Everything'; JPMorgan Earnings Miss

Futures signaled sharp losses for the market rally amid weak JPMorgan earnings and views for a massive Fed rate hike. Tesla's AI chief has left.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Futures: Market Rally Set To Fall As China Fears Return; Elon Musk-Twitter Saga Far From Over

The market rally faces a test amid renewed China concerns. Tesla CEO Elon Musk moved to end the Twitter takeover.

Investors Business Daily

IBD Stock Of The Day McKesson Leads Wholesaler Rally, Nears A Breakout

McKesson is the IBD Stock Of The Day. A drug wholesaler rally is sending McKesson stock near a breakout. Rivals are also on the rise.

Investors Business Daily

Vertex, WWE, KO Stock Among 25 Names On IBD Breakout Stocks Index

As the market regroups, 25 names — including Vertex, WWE, Li Auto and KO stock — make the IBD Breakout Stocks Index.

Investors Business Daily

Northrop Grumman Leads 5 Defensive Plays Going On Offense; All Are Near Buy Points

Northrop Grumman headlines five stocks that are near or just above buy points, with the mettle to withstand a recession.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Futures Fall: Don't Feed The Bear Market; BYD Leaves Tesla In The Dust

Don't feed the bear market, prepare for the next bull run. Tesla deliveries fell sharply in Q2 with BYD on tap.

Investors Business Daily

3 Winning Healthcare Stocks to Buy for the Rest of the Summer

Increased health awareness and the rapidly aging population are expected to drive the growth of healthcare companies. Healthcare stocks Cigna Corp. (CI), Humana (HUM), and McKesson Corp. (MCK) have bucked the market downtrend and are in momentum. Since the market is expected to remain under pressure in the near term,…

StockNews.com

Buffett Just Stocked up on These 3 Buy-Rated Stocks

Warren Buffett has been one of the most influential investors of all time. His careful methodology in picking stocks has made him a consistently successful investor. So, we think Warren Buffett stocks Occidental Petroleum (OXY), Celanese (CE), and McKesson (MCK), which are also rated Strong Buy or Buy in our…

StockNews.com

Here's How Much You Would Have Made Owning McKesson Stock In The Last 20 Years

McKesson (NYSE:MCK) has outperformed the market over the past 20 years by 5.66% on an annualized basis producing an average annual return of 12.71%. Currently, McKesson has a market capitalization of $46.56 billion.

Benzinga

Dow Jones Futures Fall: Inflation, Jobs Data Could Be Catalyst For Ailing Market Rally

The stock market rally searched for direction Wednesday. Jobless claims and inflation data are on tap.

Investors Business Daily

Dow Jones Gains; WWE Stock Slammed As Vince McMahon Steps Down; Moderna Gets Covid Vaccine Boost

The Dow Jones rallied. World Wrestling Entertainment CEO Vince McMahon stood aside amid a probe. WWE stock fell. Moderna got a vaccine boost.

Investors Business Daily

If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today

McKesson (NYSE:MCK) has outperformed the market over the past 10 years by 2.06% on an annualized basis producing an average annual return of 12.64%. Currently, McKesson has a market capitalization of $44.39 billion.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Where McKesson Stands With Analysts

Over the past 3 months, 5 analysts have published their opinion on McKesson (NYSE:MCK) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2022

Upgrades

Benzinga

$1000 Invested In McKesson 15 Years Ago Would Be Worth This Much

McKesson (NYSE:MCK) has outperformed the market over the past 15 years by 4.74% on an annualized basis producing an average annual return of 11.75%. Currently, McKesson has a market capitalization of $46.98 billion.

Benzinga

Executives Sell Over $100M Of 4 Stocks

Gold futures traded lower this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

What Is Happening With Endo Shares Today

Endo International Plc (NASDAQ:ENDP) initiated negotiations with its lenders and senior bondholders regarding a possible reorganization of more than $8 billion of its debt, the Wall Street Journal reported, citing people familiar with the matter. Lenders began talks after the company reported disappointing earnings early this month for 1Q 2022, driven by the loss…

WEKU

Idaho announces $119 million opioid crisis settlement

Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.

The Independent UK

Idaho announces $119 million opioid crisis settlement

Idaho officials have announced a $119 million settlement with drugmaker Johnson & Johnson and three major distributors over their role in the opioid addiction crisis

Benzinga

4 Analysts Have This to Say About McKesson

McKesson (NYSE:MCK) has observed the following analyst ratings within the last quarter:

Benzinga

Here's How Much You Would Have Made Owning McKesson Stock In The Last 5 Years

McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 6.7% on an annualized basis producing an average annual return of 17.83%. Currently, McKesson has a market capitalization of $49.19 billion.

Benzinga

Why McKesson Shares Are Jumping Today

McKesson Corp (NYSE:MCK) reported Q4 FY22 adjusted EPS of $5.83, +15% Y/Y, and missing the consensus of $6.04. Revenues increased 12% Y/Y to $66.10 billion, surpassing the consensus of $63.61 billion. U.S. Pharmaceutical segment's Q4 FY22 revenues were $53.67 billion, +14%, driven by an increased volume of specialty products, including higher volumes…

Benzinga

McKesson: Q4 Earnings Insights

McKesson (NYSE:MCK) reported its Q4 earnings results on Thursday, May 5, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings McKesson missed estimated earnings by 3.48%, reporting an EPS of $5.83 versus an estimate of $6.04.

1 … 3 4 5 6

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Investor Business Daily

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.